Free Trial
→ SpaceX IPO hides a much bigger story (From Weiss Ratings) (Ad)tc pixel Free BNBX Stock Alerts

Applied Dna Sciences (BNBX) Competitors

Applied Dna Sciences logo
$0.50 +0.00 (+0.24%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$0.49 -0.01 (-2.40%)
As of 05/5/2026 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

BNBX vs. ZBAI, BIAF, GFAI, NOTV, and SFHG

Should you be buying Applied Dna Sciences stock or one of its competitors? The main competitors of Applied Dna Sciences include ATIF (ZBAI), bioAffinity Technologies (BIAF), Guardforce AI (GFAI), Inotiv (NOTV), and Samfine Creation Holdings Group (SFHG). These companies are all part of the "business services" industry.

How does Applied Dna Sciences compare to ATIF?

ATIF (NASDAQ:ZBAI) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

ATIF has higher earnings, but lower revenue than Applied Dna Sciences. ATIF is trading at a lower price-to-earnings ratio than Applied Dna Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ATIF$1.20M8.46-$4.60M-$7.19N/A
Applied Dna Sciences$2.14M1.32-$15.16M-$266.22N/A

In the previous week, ATIF had 1 more articles in the media than Applied Dna Sciences. MarketBeat recorded 1 mentions for ATIF and 0 mentions for Applied Dna Sciences. ATIF's average media sentiment score of 0.00 equaled Applied Dna Sciences'average media sentiment score.

Company Overall Sentiment
ATIF Neutral
Applied Dna Sciences Neutral

ATIF's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
ATIFN/A N/A N/A
Applied Dna Sciences N/A -331.05%-258.85%

ATIF has a beta of 0.08, meaning that its stock price is 92% less volatile than the S&P 500. Comparatively, Applied Dna Sciences has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ATIF
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Applied Dna Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

22.2% of Applied Dna Sciences shares are owned by institutional investors. 32.2% of ATIF shares are owned by insiders. Comparatively, 6.1% of Applied Dna Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

ATIF beats Applied Dna Sciences on 7 of the 11 factors compared between the two stocks.

How does Applied Dna Sciences compare to bioAffinity Technologies?

Applied Dna Sciences (NASDAQ:BNBX) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

bioAffinity Technologies has higher revenue and earnings than Applied Dna Sciences. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Applied Dna Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied Dna Sciences$2.14M1.32-$15.16M-$266.22N/A
bioAffinity Technologies$6.16M1.48-$14.91M-$15.76N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Applied Dna Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
bioAffinity Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, bioAffinity Technologies had 1 more articles in the media than Applied Dna Sciences. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for Applied Dna Sciences. bioAffinity Technologies' average media sentiment score of 0.76 beat Applied Dna Sciences' score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Applied Dna Sciences Neutral
bioAffinity Technologies Positive

Applied Dna Sciences has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of -1.19, meaning that its share price is 219% less volatile than the S&P 500.

22.2% of Applied Dna Sciences shares are owned by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by insiders. Comparatively, 2.7% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Applied Dna Sciences has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -241.93%. bioAffinity Technologies' return on equity of -301.67% beat Applied Dna Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Applied Dna SciencesN/A -331.05% -258.85%
bioAffinity Technologies -241.93%-301.67%-142.38%

Summary

bioAffinity Technologies beats Applied Dna Sciences on 8 of the 13 factors compared between the two stocks.

How does Applied Dna Sciences compare to Guardforce AI?

Applied Dna Sciences (NASDAQ:BNBX) and Guardforce AI (NASDAQ:GFAI) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

Guardforce AI has higher revenue and earnings than Applied Dna Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied Dna Sciences$2.14M1.32-$15.16M-$266.22N/A
Guardforce AI$35.23M0.37-$6.66MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Applied Dna Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Guardforce AI
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Applied Dna Sciences' average media sentiment score of 0.00 equaled Guardforce AI'saverage media sentiment score.

Company Overall Sentiment
Applied Dna Sciences Neutral
Guardforce AI Neutral

Applied Dna Sciences has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Guardforce AI has a beta of 2.58, meaning that its share price is 158% more volatile than the S&P 500.

22.2% of Applied Dna Sciences shares are owned by institutional investors. Comparatively, 2.0% of Guardforce AI shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by insiders. Comparatively, 76.7% of Guardforce AI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Guardforce AI's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Applied Dna SciencesN/A -331.05% -258.85%
Guardforce AI N/A N/A N/A

Summary

Guardforce AI beats Applied Dna Sciences on 6 of the 8 factors compared between the two stocks.

How does Applied Dna Sciences compare to Inotiv?

Applied Dna Sciences (NASDAQ:BNBX) and Inotiv (NASDAQ:NOTV) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

In the previous week, Inotiv had 2 more articles in the media than Applied Dna Sciences. MarketBeat recorded 2 mentions for Inotiv and 0 mentions for Applied Dna Sciences. Inotiv's average media sentiment score of 0.81 beat Applied Dna Sciences' score of 0.00 indicating that Inotiv is being referred to more favorably in the news media.

Company Overall Sentiment
Applied Dna Sciences Neutral
Inotiv Positive

Inotiv has a consensus target price of $1.50, suggesting a potential upside of 372.44%. Given Inotiv's stronger consensus rating and higher probable upside, analysts plainly believe Inotiv is more favorable than Applied Dna Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Applied Dna Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Inotiv
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Applied Dna Sciences has a net margin of 0.00% compared to Inotiv's net margin of -13.50%. Inotiv's return on equity of -28.95% beat Applied Dna Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Applied Dna SciencesN/A -331.05% -258.85%
Inotiv -13.50%-28.95%-5.22%

Applied Dna Sciences has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Inotiv has a beta of 3.82, meaning that its share price is 282% more volatile than the S&P 500.

22.2% of Applied Dna Sciences shares are owned by institutional investors. Comparatively, 18.2% of Inotiv shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by insiders. Comparatively, 7.8% of Inotiv shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Applied Dna Sciences has higher earnings, but lower revenue than Inotiv. Inotiv is trading at a lower price-to-earnings ratio than Applied Dna Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied Dna Sciences$2.14M1.32-$15.16M-$266.22N/A
Inotiv$513.02M0.02-$68.62M-$2.03N/A

Summary

Inotiv beats Applied Dna Sciences on 11 of the 16 factors compared between the two stocks.

How does Applied Dna Sciences compare to Samfine Creation Holdings Group?

Samfine Creation Holdings Group (NASDAQ:SFHG) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

In the previous week, Samfine Creation Holdings Group's average media sentiment score of 0.00 equaled Applied Dna Sciences'average media sentiment score.

Company Overall Sentiment
Samfine Creation Holdings Group Neutral
Applied Dna Sciences Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Samfine Creation Holdings Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Applied Dna Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Samfine Creation Holdings Group's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Samfine Creation Holdings GroupN/A N/A N/A
Applied Dna Sciences N/A -331.05%-258.85%

Samfine Creation Holdings Group has a beta of 2.09, meaning that its stock price is 109% more volatile than the S&P 500. Comparatively, Applied Dna Sciences has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500.

22.2% of Applied Dna Sciences shares are held by institutional investors. 6.1% of Applied Dna Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Samfine Creation Holdings Group has higher revenue and earnings than Applied Dna Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Samfine Creation Holdings Group$21.82M0.46-$2.55MN/AN/A
Applied Dna Sciences$2.14M1.32-$15.16M-$266.22N/A

Summary

Samfine Creation Holdings Group beats Applied Dna Sciences on 5 of the 8 factors compared between the two stocks.

Get Applied Dna Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNBX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNBX vs. The Competition

Export
MetricApplied Dna SciencesServices – Research, Development, Testing Labs IndustryServices SectorNASDAQ Exchange
Market Cap$2.83M$11.83M$994.74M$11.76B
Dividend YieldN/AN/A4.67%5.26%
P/E Ratio0.00N/A15.7127.07
Price / Sales1.324.4825.4273.40
Price / CashN/AN/A388.0053.90
Price / Book0.330.336.596.69
Net Income-$15.16M-$15.16M$1.76M$332.64M
7 Day Performance-2.15%-2.01%1.78%3.07%
1 Month Performance-20.63%-15.62%17.28%7.80%
1 Year PerformanceN/AN/A-3.61%41.57%

Applied Dna Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BNBX
Applied Dna Sciences
0.0939 of 5 stars		$0.50
+0.2%		N/AN/A$2.83M$2.14MN/A70
ZBAI
ATIF
0.3161 of 5 stars		$8.44
-5.3%		N/A-53.5%$11.14M$1.20MN/A10
BIAF
bioAffinity Technologies
0.3648 of 5 stars		$2.43
-8.6%		N/A-82.3%$10.94M$6.16MN/A10
GFAI
Guardforce AI
0.6389 of 5 stars		$0.51
-8.8%		N/A-47.5%$10.76M$35.23MN/A1,547
NOTV
Inotiv
1.5678 of 5 stars		$0.31
+7.3%		$1.50
+385.4%		-84.4%$10.63M$514.03MN/A2,046

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BNBX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
How to collect $1,170/month from silver
There is a silver fund paying up to 20% in yearly distributions - no mining stocks, no options required. The s...
Investors Alley | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Did you miss The Dark AI Summit?
Over 55,000 people attended Jeff Brown's Dark AI Summit, where he revealed a private AI company he believes ho...
Brownstone Research | Sponsoredtc pixel
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next
Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...
Paradigm Press | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel